2 Patents
- US116334082023Prevention of Adverse Effects Caused by CD3 Specific Binding Domains
AMGEN RESEARCH (MUNICH) GmbH
0 cites - US115791422023Dosage Regimen for Administering a Cd19xcd3 Bispecific Antibody to Patients at Risk for Potential Adverse Effects
AMGEN RESEARCH (MUNICH) GmbH
0 cites